Cathay Pacific has become a full member of Pharma.Aero, a cross-industry collaboration for pharma shippers, CEIV-certified cargo communities, airport operators and other air cargo industry stakeholders.
Cathay Pacific, CEIV Pharma certified since October 2017, says the move will strengthen Hong Kong’s status as a world-leading air cargo hub.
Pharma.Aero, whose aim is to achieve excellence in the reliable, end-to-end air transportation and handling of high-value, time-sensitive pharmaceutical products, announced Cathay Pacific’s membership today at the IATA World Cargo Symposium in Singapore.
“This collaborative approach with the pharmaceutical industry undoubtedly boosts Hong Kong’s reputation as a world-class hub for the handling of these high-value and time-sensitive products,” says Nelson Chin, Cathay Pacific general manager Cargo Commercial.
“As Hong Kong’s home airline, Cathay Pacific is working closely with Airport Authority Hong Kong to develop a pharma ‘corridor’ to connect airport members of Phama.Aero and provide customers with a superior service.”
With the carridor pharmaceutical shipments will be handled in strict compliance with the IATA’s CEIV Pharma standard. Under this process shippers will be assured of seamless airport-to-airport (A2A) temperature-controlled handling, assuring the integrity of the shipments.
Nathan De Valck, chairman of Pharma.Aero adds: “We are excited about Cathay Pacific joining our collaboration group as a full member. Their active involvement in the pilot of the pharma corridor project is a clear added value. In collaboration with Pharma.Aero and our pharma shipper members, key performance indicators of the pharma corridor will be clearly defined, targeting to set A2A pharma handling standards.”